Vitamin B7 (Biotin): History and Discovery

The story of biotin begins, oddly enough, with raw egg whites and a mysterious illness in animals. In the early twentieth century, researchers noticed that diets heavy in raw egg white made laboratory animals lose their fur, develop scaly skin, and grow weak — the so-called "egg-white injury." The hunt for the substance that cured that injury, pursued by several teams who did not at first realise they were chasing the same molecule, is the discovery story of vitamin B7. The same compound was found independently as a yeast growth factor (named biotin), as a bacterial growth factor (named coenzyme R), and as the skin-and-hair vitamin (named vitamin H) — three names for one vitamin, finally united in 1940. This page traces that convergence: the egg-white puzzle, the rival names, the crystallisation by Fritz Kögl and Benno Tönnis in 1936, the structure worked out by Vincent du Vigneaud's laboratory in 1942, and the first laboratory synthesis at Merck in 1943. Where a date or a claim of priority is firm we say so; where it is debated or uncertain, we say that too.

Table of Contents

  1. The Egg-White Puzzle (1916–1927)
  2. Three Names for One Molecule
  3. Isolation and the Name "Biotin" (Kögl & Tönnis, 1936)
  4. Vitamin H: György and the Hair-and-Skin Factor
  5. One Vitamin at Last: The 1940 Identity
  6. Proof in People: The 1942 Human Experiment
  7. The Structure of Biotin (du Vigneaud, 1942)
  8. First Synthesis and the Prizes (Merck, 1943)
  9. Where Casimir Funk and "Vitamine" Fit In
  10. From Curiosity to Cornerstone
  11. Research Papers and References
  12. Connections
  13. Featured Videos

The Egg-White Puzzle (1916–1927)

Biotin's discovery did not start with the vitamin at all. It started with a strange poisoning. In 1916, the American researcher W. G. Bateman reported that animals fed diets containing large amounts of raw egg white developed toxic symptoms — an early clue that something about raw egg white was harmful when it dominated the diet. The phenomenon came to be called "egg-white injury."

The clearest early description of the syndrome came in 1927 from Margarete Boas (often working in this area alongside Helen Parsons), who fed rats raw egg white as their main protein source and watched them develop a consistent picture: dermatitis (an angry, scaly skin rash), alopecia (hair loss), and loss of muscular coordination. Crucially, Boas also discovered that something in liver could prevent and cure the injury. She could not yet say what that something was, so she gave it a placeholder name — a "protective factor." That protective factor would, more than a decade later, turn out to be biotin.

It is worth pausing on how the mechanism works, because it is the thread that ties the whole story together. Raw egg white contains a protein called avidin, which clamps onto biotin so tightly that the vitamin can no longer be absorbed from the gut. Feeding lots of raw egg white therefore does not add a poison so much as it removes a vitamin — it starves the animal of biotin. (Cooking destroys avidin, which is why cooked eggs cause no such problem and egg yolk is in fact biotin-rich.) The early researchers had stumbled, without knowing it, onto a clean experimental way to create a vitamin deficiency, and that is precisely why the egg-white injury became the doorway to discovering the vitamin.

Back to Table of Contents

Three Names for One Molecule

One reason biotin's history is so tangled — and so instructive — is that three different lines of research found the same compound at roughly the same time, each from a completely different starting point, and each gave it a different name. For years, scientists did not realise they were all describing one molecule.

The first line was the bacterial one. In 1933, the American researchers F. E. Allison (Franklin E. Allison), S. R. Hoover, and Dean Burk identified a substance that nitrogen-fixing root-nodule bacteria (Rhizobium, the bacteria that live in the roots of beans, peas, and clover) needed in order to grow and respire, reporting it in Science under the title "A Respiration Coenzyme." They called it coenzyme R. (The substance was tied directly to biotin a few years later, in 1939, when West and Wilson showed in a short Science note that "coenzyme R" and biotin were the same thing.) The second line was the yeast one, which led to the name "biotin" (covered in the next section). The third line was the nutritional one — the egg-white injury story — which produced the name "vitamin H."

So by the late 1930s the same vitamin was wearing three hats: a growth factor for bacteria (coenzyme R), a growth factor for yeast (biotin), and a deficiency-curing nutrient for animals (vitamin H). This is a recurring pattern in vitamin history — the same molecule being important to wildly different living things — but biotin is one of the cleanest examples of it, and the eventual proof that the three were identical is the centrepiece of its discovery.

Back to Table of Contents

Isolation and the Name "Biotin" (Kögl & Tönnis, 1936)

The single most important step toward holding the vitamin in hand came in 1936, in the Netherlands. The German-born chemist Fritz Kögl, working at the University of Utrecht with his colleague Benno Tönnis, succeeded in isolating a crystalline growth factor for yeast from egg yolk. They published their result under the title "Darstellung von krystallisiertem Biotin aus Eigelb" — roughly, "Preparation of crystalline biotin from egg yolk." This was a feat of patience: the active substance is present in only minute amounts, so vast quantities of egg yolk had to be processed to obtain a tiny amount of pure crystals.

Kögl and Tönnis gave their crystals the name biotin, from the Greek bios, meaning "life" (the same root that gives us "biology"). The name was fitting: the substance was essential to the growth of living yeast cells. With a pure, crystalline compound finally available, the question of what biotin actually was — its chemical structure — could at last be tackled, and the question of whether it was the same as the egg-white-injury factor and coenzyme R could finally be tested directly rather than guessed at.

A note of honesty about Fritz Kögl is in order. Kögl was a gifted and important chemist, but some of his other work from the same era — in particular a famous claim about a difference between cancerous and healthy tissue in their amino-acid composition — later fell under a serious cloud of doubt and could not be reproduced, and his reputation is genuinely debated by historians of science. His biotin isolation, however, stands: the crystallisation of biotin from egg yolk in 1936 is well documented and was confirmed by the work that followed. We separate the two here so as not to let a later controversy distort a real and verified achievement.

Back to Table of Contents

Vitamin H: György and the Hair-and-Skin Factor

While Kögl was crystallising a yeast factor, the Hungarian-born American physician-scientist Paul György was chasing the egg-white injury from the nutritional side. György — already well known in vitamin research (he is also credited in the discovery of vitamin B6) — set out to identify the protective factor that liver supplied against egg-white injury. In 1939 he reported success, naming the curative substance vitamin H.

The letter "H" is a small linguistic fossil of the discovery itself. It comes from the German words Haar and Haut — "hair" and "skin" — because those were the tissues most visibly wrecked by the deficiency and most visibly rescued by the cure. This is the historical root of biotin's enduring modern reputation as the "hair, skin, and nails" vitamin: long before anyone marketed it for beauty, the vitamin earned its very name from what its absence did to hair and skin.

So as the 1930s closed, the puzzle pieces were on the table but not yet joined: a crystalline yeast factor called biotin, a bacterial factor called coenzyme R, and a nutritional anti-dermatitis factor called vitamin H. The obvious and pressing question — were these the same thing? — was about to be answered.

Back to Table of Contents

One Vitamin at Last: The 1940 Identity

The convergence came in 1940. In a paper in the journal Science titled "The Possible Identity of Vitamin H with Biotin and Coenzyme R," Paul György, Donald B. Melville, Dean Burk, and Vincent du Vigneaud reported the evidence that the three substances chased down by three separate research traditions were one and the same molecule. The nutritional vitamin H, the yeast factor biotin, and the bacterial coenzyme R collapsed into a single compound.

This is the moment the modern vitamin is born as a single, agreed-upon entity. By convention the name that survived was biotin — Kögl and Tönnis's name — while "vitamin H" faded into a historical synonym (still occasionally seen on old labels) and "coenzyme R" receded into the bacteriology literature. The episode is a textbook example of why scientific names matter and why duplicate discovery is so common: three competent groups, looking at yeast, at bacteria, and at sick animals, had each grasped a different part of the same elephant.

It is fair to call this a resolved priority question rather than a bitter dispute. Each group had genuinely discovered something real; the 1940 paper's achievement was not to crown a single winner but to show that the prizes were the same prize. Notice, too, that Vincent du Vigneaud appears as one of the authors here — his laboratory was moving from confirming identity to the harder problem of structure, which is the next chapter.

Back to Table of Contents

Proof in People: The 1942 Human Experiment

Until the early 1940s, the egg-white injury and its cure had been demonstrated mainly in animals. The decisive demonstration in humans came in 1942, when Virgil P. Sydenstricker and colleagues at the University of Georgia published "Preliminary Observations on 'Egg White Injury' in Man and Its Cure with a Biotin Concentrate" in Science.

The experiment was direct and, by today's standards, remarkably bold: healthy adult volunteers were placed on a diet rich in raw egg white and stripped of biotin-containing foods. Within a few weeks they developed the now-familiar signs — a scaly dermatitis, grey pallor, fatigue, muscle pains, nausea, and a kind of depression and lassitude. When the volunteers were then given a biotin concentrate, the symptoms cleared. This closed the loop: biotin was not merely a growth factor for yeast and bacteria, it was an essential nutrient for people, and its deficiency produced a defined illness that biotin reversed. It is one of the clearest deficiency-and-cure demonstrations in the history of the B vitamins.

Back to Table of Contents

The Structure of Biotin (du Vigneaud, 1942)

Knowing that a vitamin exists and can be crystallised is not the same as knowing what it is — the actual arrangement of its atoms. That harder problem was solved in 1942 by the American biochemist Vincent du Vigneaud and his group at Cornell University Medical College, with key contributions from co-workers including Klaus Hofmann and Donald B. Melville. Their landmark report, "The Structure of Biotin," appeared in Science in 1942.

Biotin proved to be a fascinating molecule: a fused two-ring structure (a ureido ring joined to a sulphur-containing tetrahydrothiophene ring) carrying a short fatty-acid side chain. The presence of sulphur in the molecule was a notable feature and fit du Vigneaud's lifelong scientific theme — he is often described as having "followed the sulphur trail" through biochemistry, from biotin to penicillin to the pituitary hormones. Working out this structure required clever chemical detective work, including the study of a closely related breakdown product called desthiobiotin, to pin down how the atoms were connected.

With the structure in hand, biotin moved decisively from a biological mystery into a defined chemical compound — one that chemists could now attempt to build from scratch.

Back to Table of Contents

First Synthesis and the Prizes (Merck, 1943)

The final classical milestone in biotin's discovery was making it artificially. The first total chemical synthesis of biotin was accomplished in 1943 by a team at the research laboratories of Merck & Co. led by Stanton A. Harris and including Karl Folkers and several colleagues. Their work was first announced in a short note titled "Synthetic Biotin" in Science in 1943 and then set out in full in the Journal of the American Chemical Society in 1944; it built biotin in the laboratory and in doing so independently confirmed that the structure du Vigneaud's group had proposed was correct — the synthetic molecule behaved exactly like the natural vitamin.

Now for the honest part about prizes, because biotin's history is often loosely described. Vincent du Vigneaud did receive major recognition that included his biotin work: in 1948 he was awarded an Albert Lasker Award, with his citation covering contributions to the structure and synthesis of biotin and penicillin. He later won the Nobel Prize in Chemistry in 1955 — but it is important to state plainly that that Nobel was not for biotin. The 1955 prize was awarded for his work on biochemically important sulphur compounds, especially the first synthesis of a polypeptide hormone (the pituitary hormone oxytocin). Biotin was part of the body of sulphur chemistry that built his reputation, and it shares the "sulphur trail" theme, but anyone who says "du Vigneaud won the Nobel Prize for biotin" is overstating the record. There was no Nobel Prize specifically for the discovery of biotin.

Karl Folkers, who helped synthesise biotin at Merck, went on to a celebrated career isolating and synthesising other vitamins — he played a leading role in isolating vitamin B12 and in the chemistry of coenzyme Q10 — and was widely honoured for it, receiving the Perkin Medal in 1960 and, much later, the U.S. National Medal of Science. (He is sometimes loosely described as a "Lasker laureate," but he does not appear among the Albert Lasker Award winners; we note that here rather than repeat the error.) Either way, his career is another reminder that biotin's chemistry sat at the centre of a golden age of mid-century vitamin research.

Back to Table of Contents

Where Casimir Funk and "Vitamine" Fit In

No vitamin history is complete without the man who gave the whole class its name. In 1912, the Polish-born biochemist Casimir Funk, then working in London, proposed the word "vitamine" for a class of essential dietary factors whose absence caused diseases such as beriberi, scurvy, pellagra, and rickets. He coined the term by joining the Latin vita ("life") with "amine," because he believed these factors were chemical amines. They were not all amines, so the final "e" was later dropped to give the modern "vitamin."

Funk did not discover biotin — his coinage predates biotin's isolation by more than two decades. But his framework is the reason biotin has the identity it does. When Kögl, György, and the others were working in the 1930s, they were searching explicitly for "vitamins" in Funk's sense: trace dietary substances, essential to life, whose lack produced a specific disease. Biotin slotted neatly into that concept. Its very name — from the Greek for "life" — even echoes the vita in Funk's "vitamine." And unlike one or two of the B-numbers that were later demoted (the designation once used for "vitamin B4," for example, does not correspond to a substance now classed as a true vitamin), biotin has never lost its standing: it is a genuine, essential, water-soluble member of the B-complex, exactly the kind of factor Funk had in mind.

Back to Table of Contents

From Curiosity to Cornerstone

The decades after the structure and synthesis transformed biotin from a hard-won laboratory curiosity into a molecule we understand at the level of single atoms and single genes. Biotin was shown to be the essential helper (a coenzyme) for a family of carboxylase enzymes that sit at the crossroads of how the body handles fats, sugars, and proteins. Later research uncovered the inherited disorders of biotin handling — biotinidase deficiency and the multiple carboxylase deficiencies — in which the body cannot recycle or attach biotin properly; these are now screened for at birth in many countries, and lifelong biotin can prevent what was once devastating neurological damage. More recently, biotin has even been found to play a role in switching genes on and off, and high doses have been studied (with mixed results) in progressive multiple sclerosis.

Looked at as a whole, biotin's history is a small masterpiece of how science actually works: a chance observation about egg whites, three teams chasing what they thought were three different substances, a painstaking crystallisation, a structure solved atom by atom, and a synthesis that proved the answer right — followed by a slow, ongoing deepening of understanding. The detailed modern science — what biotin does in the body, who is at risk of deficiency, food sources, dosing, and the important caution that biotin supplements can distort certain laboratory blood tests — is covered in the companion Vitamin B7 Benefits articles and on the main Vitamin B7 (Biotin) page. This history is concerned with how we came to know the vitamin at all.

Back to Table of Contents

Research Papers and References

The list below gathers key primary papers from biotin's discovery together with a modern history review and curated PubMed topic-search links. Author names, titles, and journals are given as plain text; only the stable PMID or DOI is hyperlinked, and each opens in a new tab. Several of the original 1940s papers are old enough that only an archival PubMed record exists; those records are linked where available.

  1. Lanska DJ. The discovery of niacin, biotin, and pantothenic acid. Annals of Nutrition and Metabolism. 2012;61(3):246-253. — doi:10.1159/000343115 (PMID: 23183297)
  2. György P, Melville DB, Burk D, du Vigneaud V. The possible identity of vitamin H with biotin and coenzyme R. Science. 1940;91(2358):243-245. — PMID: 17831182
  3. Sydenstricker VP, Singal SA, Briggs AP, DeVaughn NM, Isbell H. Preliminary observations on "egg white injury" in man and its cure with a biotin concentrate. Science. 1942;95(2459):176-177. — PMID: 17818887
  4. du Vigneaud V. The structure of biotin. Science. 1942;96(2499):455-461. — doi:10.1126/science.96.2499.455
  5. Mock DM. Biotin: from nutrition to therapeutics. The Journal of Nutrition. 2017;147(8):1487-1492. — doi:10.3945/jn.116.238956 (PMID: 28701385)
  6. Biotin discovery and history — PubMed: biotin history and discovery
  7. Biotin deficiency and egg-white injury — PubMed: biotin deficiency and avidin

External Authoritative Resources

Back to Table of Contents

Connections

Back to Table of Contents